The designation 2700078E11Rik Activators is assigned to a category of chemical compounds that can induce the expression of the 2700078E11Rik gene. To identify activators within this class, researchers employ high-throughput screening (HTS), a technique capable of quickly evaluating vast numbers of chemicals for their ability to modulate gene activity. This process uses a reporter gene assay, where a detectable reporter - often a luminescent or fluorescent protein - is placed under the control of the 2700078E11Rik gene promoter. When a compound from the chemical library activates this promoter, the reporter gene is expressed, and the emitted signal is measured. The intensity of the signal is proportional to the activating potential of the compound. Compounds that lead to a marked upsurge in reporter activity are singled out for additional analysis. This step is critical for narrowing down the field to those compounds that can specifically elevate the activity of the 2700078E11Rik gene out of a large set of chemical entities.
An observed increase in mRNA concentration relative to control samples suggests an activation effect at the transcriptional level. To ensure that this transcriptional activation translates into an actual protein increase, Western blot analysis is conducted. This method separates proteins in a sample by gel electrophoresis, transfers them to a membrane, and uses specific antibodies to detect the protein product of the 2700078E11Rik gene. A verified increase in the target protein upon interaction with the compound solidifies its status as an activator. These methods, qPCR and Western blot, are indispensable in the validation process, providing a detailed assessment of a compound's ability to not only promote mRNA production but also enhance protein synthesis. The thorough application of these techniques ensures that the role of a compound as a gene activator is reliably characterized, establishing a concrete and measurable increase in gene expression from the transcriptional stage through to protein production.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. This rise in calcium can activate calmodulin-dependent kinases, which may then enhance the signaling pathways in which 2700078E11Rik Protein is involved. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a PKC activator that mimics diacylglycerol. Activation of PKC can lead to the phosphorylation of effector proteins that are part of the signal transduction pathway involving 2700078E11Rik Protein, thus enhancing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter downstream signaling, potentially leading to activation of compensatory pathways that enhance the activity of 2700078E11Rik Protein through feedback mechanisms. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is an MEK inhibitor that can lead to reduced ERK phosphorylation. By inhibiting this pathway, there could be a compensatory activation of parallel pathways involving 2700078E11Rik Protein, thereby enhancing its functional activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. Inhibition of p38 MAPK can lead to an upregulation of alternative signaling routes that enhance the activity of 2700078E11Rik Protein through a feedback loop. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium concentrations, which can activate calcium-dependent signaling pathways and thereby enhance the activity of 2700078E11Rik Protein. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
SB216763 is an inhibitor of GSK3. Inhibition of GSK3 could lead to activation of Wnt signaling, which may then enhance the functional activity of 2700078E11Rik Protein through cross-talk with associated signaling pathways. | ||||||
L-NG-Nitroarginine Methyl Ester (L-NAME) | 51298-62-5 | sc-200333 sc-200333A sc-200333B | 1 g 5 g 25 g | $47.00 $105.00 $322.00 | 45 | |
L-NAME is an inhibitor of nitric oxide synthase. By reducing NO levels, it can influence signaling pathways that might enhance the activity of 2700078E11Rik Protein by altering the cellular redox state and modulating protein activity through redox-sensitive switches. |